Oral Session 3-12B AML: Leukemogenesis

[OS3-12B-5] A novel fusion HNRNPC-RARB in acute promyelocytic leukemia without RARA translocation

Kaoru Yoshida¹, Akihiro Watanabe², Tomoo Osumi^1,3, Shunsuke Kimura⁴, Kazuhiko Nakabayashi⁵, Hiroko Ogata⁵, Kohji Okamura⁶, Ryota Shirai¹, Masanori Yoshida¹, Shinichi Tsujimoto³, Daisuke Tomizawa³, Hiroyuki Takahashi⁷, Kimikazu Matsumoto³, Seishi Ogawa⁸, Nobutaka Kiyokawa¹, Susumu Goyama⁹, Kenichiro Hata⁵, Motohiro Kato^1,3 (1.Department of Pediatric Hematology and Oncology Research, NCCHD, Tokyo, Japan, 2.Department of pediatrics, Niigata Cancer Center Hospital, Niigata, Japan, 3.Children's Cancer Center, NCCHD, Tokyo, Japan, 4.Department of Pediatrics, The University of Tokyo, Tokyo, Japan, 5.Department of Maternal-Fetal Biology, NCCHD, Tokyo, Japan, 6.Department of Systems BioMedicine, NCCHD, Tokyo, Japan, 7.Department of Pediatrics, Toho University, Tokyo, Japan, 8.Dept. Pathology and Tumor Biology, Kyoto University, Kyoto, Japan, 9.Div. Cellular Therapy, Inst. Medical Science, Univ. Tokyo, Tokyo, Japan)